DK103891D0 - Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon - Google Patents

Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon

Info

Publication number
DK103891D0
DK103891D0 DK911038A DK103891A DK103891D0 DK 103891 D0 DK103891 D0 DK 103891D0 DK 911038 A DK911038 A DK 911038A DK 103891 A DK103891 A DK 103891A DK 103891 D0 DK103891 D0 DK 103891D0
Authority
DK
Denmark
Prior art keywords
recombinant human
carcinoma
pladeepetal
intralaesional
alfainterferon
Prior art date
Application number
DK911038A
Other languages
Danish (da)
English (en)
Other versions
DK103891A (da
Inventor
Daniel J Tanner
Edwin A Peets
Kenneth A Smiles
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK103891D0 publication Critical patent/DK103891D0/da
Publication of DK103891A publication Critical patent/DK103891A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK103891A 1988-12-01 1991-05-31 Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon DK103891A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27831588A 1988-12-01 1988-12-01
PCT/US1989/005287 WO1990006135A1 (en) 1988-12-01 1989-11-29 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Publications (2)

Publication Number Publication Date
DK103891D0 true DK103891D0 (da) 1991-05-31
DK103891A DK103891A (da) 1991-05-31

Family

ID=23064525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK103891A DK103891A (da) 1988-12-01 1991-05-31 Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon

Country Status (14)

Country Link
EP (2) EP0446279A1 (xx)
JP (1) JPH0647556B2 (xx)
KR (1) KR950011889B1 (xx)
AT (1) ATE92333T1 (xx)
AU (1) AU634511B2 (xx)
CA (1) CA2004202C (xx)
DE (1) DE68908119T2 (xx)
DK (1) DK103891A (xx)
ES (1) ES2058555T3 (xx)
IE (1) IE63121B1 (xx)
IL (1) IL92495A (xx)
MY (1) MY107071A (xx)
WO (1) WO1990006135A1 (xx)
ZA (1) ZA899113B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563177A1 (en) * 1990-12-14 1993-10-06 Schering Corporation Oral administration of alpha interferon to treat lung malignancies
WO1992011025A2 (en) * 1990-12-21 1992-07-09 Schering Corporation Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
JP4156028B2 (ja) * 1995-10-04 2008-09-24 シェーリング コーポレイション 進行癌の処置のためのテモゾロミドとα−ＩＦＮの組合せ
US7294332B2 (en) 1995-10-04 2007-11-13 Schering Corporation Combination therapy (temozolomide and α-IFN) for advanced cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305551A3 (en) * 1981-10-13 1990-01-10 Exovir, Inc. Pharmaceutical compositions for topical application
AU601741B2 (en) * 1986-05-27 1990-09-20 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
MY107071A (en) 1995-09-30
IL92495A0 (en) 1990-08-31
JPH04500678A (ja) 1992-02-06
IE63121B1 (en) 1995-03-22
KR950011889B1 (ko) 1995-10-12
DE68908119T2 (de) 1993-11-18
AU634511B2 (en) 1993-02-25
ATE92333T1 (de) 1993-08-15
ZA899113B (en) 1990-08-29
JPH0647556B2 (ja) 1994-06-22
CA2004202C (en) 2001-02-13
DE68908119D1 (de) 1993-09-09
CA2004202A1 (en) 1990-06-01
EP0372809B1 (en) 1993-08-04
KR900701311A (ko) 1990-12-01
EP0446279A1 (en) 1991-09-18
WO1990006135A1 (en) 1990-06-14
DK103891A (da) 1991-05-31
ES2058555T3 (es) 1994-11-01
AU4802590A (en) 1990-06-26
EP0372809A1 (en) 1990-06-13
IE893828L (en) 1990-06-01
IL92495A (en) 1995-05-26

Similar Documents

Publication Publication Date Title
DK486588A (da) Konjungater af cytokininer med immunglobuliner
NO176665C (no) Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav
DK0652966T3 (da) Fremgangsmåde til forøgelse af ekspression af virale proteiner
DK478786D0 (da) Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner
DK103891D0 (da) Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
DK50987A (da) Polypeptid med plasminogenaktivatorvirkning
ES2036526T3 (es) Composiciones de interferon.
DK0382381T3 (da) Behandling af leukocyt-dysfunktion med GM-CSF
DK31386A (da) Behandling af proliferative hudsygdomme
DK328088A (da) Farmaceutisk komposition til behandling af tumorer
EP0248583A3 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0276120A3 (en) Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
DE3750248D1 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
DE3777224D1 (de) Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
DK527287D0 (da) Polypeptid med interleukin-2-aktiviteter
DK0381584T3 (da) Anvendelse af visse gamma-interferoner til behandling af ovariecancer
ATE54941T1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment